Compass Therapeutics
Price & Volume
Stats
See more52W Range | $1.33-$6.88 |
Market Cap | $1B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.45 |
News
See moreYahoo Finance • 22 hours ago
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
Yahoo Finance • 3 months ago
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference
Yahoo Finance • 3 months ago
Here Are Wednesday’s Top Wall Street Analyst Upgrades and Downgrades: American Eagle Outfitters, Equinix, Garmin, Honeywell, Uber, Wendy’s and More
Yahoo Finance • 3 months ago
Compass Therapeutics to Participate in Upcoming December Investor Events
About
CEO | Dr. Thomas J. Schuetz M.D., Ph.D. |
Address | 80 Guest Street, Boston, MA, United States, 02135 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 35 |
